Tab Application Banner
  • Users Online: 302
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2006  |  Volume : 1  |  Issue : 1  |  Page : 13-19

Biological therapy in rheumatoid arthritis: current status

1 Postgraduate Department of General Medicine, Government Medical College, Jammu (J & K), India
2 Postgraduate Department of Pharmacology and Therapeutics, Government Medical College, Jammu (J & K), India

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

With the development of biological agents our therapeutic approach to rheumatoid arthritis (RA) and inflammatory diseases in general, has dramatically changed in the last few years. Recently, a number of endogenous molecules have been identified that are known to activate CD4+ T cells leading to production of cytokines (IL-1, IL-6 and TNF-α), immunoglobulins like rheumatoid factor and expression of osteoprotegerin ligands that stimulate osteoge- nesis leading to joint destruction. This has led to better insight into the disease mechanisms. As a result, there is a wave of new therapies for RA like infliximab, adalimumab, atlizumab, etanercept, anakinra, prosorba column, abatacept, anti-IL-6 agents, IL-10 and interferon-γ. To date, combination therapy of methotrexate and a single bio- logical has been widely studied with synergistic effect. Etanercept and infliximab are the two biologicals available in India. Present article can prove useful for the physicians to get an insight into these novel therapeutic options for RA.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded63    
    Comments [Add]    

Recommend this journal